Biotechnology Stocks II Performance Guide: Fate Therapeutics, Inc. (FATE)
FATE has no dividends.
Table and Chart of FATE Performance
See what a $1,000 investment in FATE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| FATE Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $6.99 |
| End Date | May-16-2024 |
| End Price | $4.14 |
| # Prices | 121 |
| Min Date | May-31-2016 |
| Min Price | $1.53 |
| Max Date | Dec-31-2020 |
| Max Price | $90.93 |
| Total Return | -40.77% |
| Annualized Return | -5.06% |
| Current Value of $1,000 Purchase | $592 |
| Number Returns | 7,260 |
| Average Return | 345.79% |
| Number Profitable Returns | 4,780 |
| Percent Profitable Returns | 65.84% |
| Number Unprofitable Returns | 2,480 |
| Percent Unprofitable Returns | 34.16% |
| Profitable to Unprofitable Returns Ratio | 1.93 |
| FATE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $482,648,000 |
| Beta | 1.799 | Price to Sales | 10.33 |
| Earnings per Share | $-1.9200 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 1.785 |
| PRICE DATA | |
| 52 Week High | $8.83 |
| 52 Week Low | $1.63 |
| Analyst Target Price | $6.93 |
| 50-Day Moving Average | $5.85 |
| 200-Day Moving Average | $4.048 |
| FINANCIAL DATA | |
| Revenue per Share | $0.065 |
| Revenue | $6,478,000 |
| Profit Margin | 0% |
| Return on Equity | -42.1% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
FATE Compare Returns with S&P 500
FATE Trendline Chart
FATE Moving Average Chart
FATE Stock Return Map - See Patterns of Gains and Losses
FATE Stock Returns/Purchase Dates